PS
HQL

Principal Securities’s abrdn Life Sciences Investors HQL Stock Holding History

Principal Securities’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-768
Closed -$11.9K – 2310
2025
Q3 		$11.9K Hold
768
– – ﹤0.01% 2647
2025
Q2 		$9.84K Hold
768
– – ﹤0.01% 2623
2025
Q1 		$10.1K Hold
768
– – ﹤0.01% 2521
2024
Q4 		$10.1K Hold
768
– – ﹤0.01% 2517
2024
Q3 		$11.6K Hold
768
– – ﹤0.01% 2370
2024
Q2 		$10.9K Buy
768
+25
+3% +$338 ﹤0.01% 2345
2024
Q1 		$10.1K Hold
743
– – ﹤0.01% 2330
2023
Q4 		$10K Buy
+743
New +$9.14K ﹤0.01% 2240

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Principal Securities's HQL Position: Q4 2025 in Review

Principal Securities sold out of abrdn Life Sciences Investors (HQL) in Q4 2025, closing a stake of 768 shares — an estimated $11.9K sold.

Principal Securities first reported a position in HQL in Q4 2023 and held it in 8 quarters. The position peaked at $11.9K in Q3 2025. 73 funds tracked by Wall St. Rank hold HQL as of Q4 2025.

  • Principal Securities reported no remaining abrdn Life Sciences Investors position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 768 abrdn Life Sciences Investors shares in Q4 2025, an estimated $11.9K.
  • Principal Securities first reported a position in abrdn Life Sciences Investors in Q4 2023 and held it in 8 quarters.
  • Principal Securities's abrdn Life Sciences Investors position peaked at $11.9K in Q3 2025.
  • 73 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.